EDITORIAL
Published on 29 Nov 2021
Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances
doi 10.3389/fmed.2021.778352
- 1,088 views
- Frontiers in Medicine
- Hematology
- Research Topics
- Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances
Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances
10k
Total Downloads
51k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
CASE REPORT
Published on 02 Mar 2021
Case Report: Microangiopathic Hemolytic Anemia With Normal ADAMTS13 Activity
doi 10.3389/fmed.2021.589423
- 6,067 views
- 1 citation
ORIGINAL RESEARCH
Published on 26 Feb 2021
Retrospective and Systematic Analysis of Causes and Outcomes of Thrombotic Microangiopathies in Routine Clinical Practice: An 11-Year Study
doi 10.3389/fmed.2021.566678
- 3,457 views
- 12 citations
BRIEF RESEARCH REPORT
Published on 26 Feb 2021
Diagnosis of Hereditary TTP Caused by Homozygosity for a Rare Complex ADAMTS13 Allele After Salmonella Infection in a 43-Year-Old Asylum Seeker
doi 10.3389/fmed.2021.639441
- 2,268 views
- 3 citations
MINI REVIEW
Published on 18 Dec 2020
Immature Platelet Dynamics in Immune-Mediated Thrombocytopenic States
doi 10.3389/fmed.2020.597734
- 4,652 views
- 15 citations
ORIGINAL RESEARCH
Published on 03 Nov 2020
Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant
doi 10.3389/fmed.2020.579418
- 2,866 views
- 9 citations
ORIGINAL RESEARCH
Published on 28 Oct 2020
Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab
doi 10.3389/fmed.2020.588526
- 5,770 views
- 7 citations
CASE REPORT
Published on 22 Oct 2020
Refractory Auto-Immune Thrombotic Thrombocytopenic Pupura Successfully Treated With Caplacizumab
doi 10.3389/fmed.2020.549931
- 2,056 views
- 4 citations
ORIGINAL RESEARCH
Published on 06 Oct 2020
Validation of Early Increase in Complement Activation Marker sC5b-9 as a Predictive Biomarker for the Development of Thrombotic Microangiopathy After Stem Cell Transplantation
doi 10.3389/fmed.2020.569291
- 3,562 views
- 17 citations
CASE REPORT
Published on 30 Jun 2020
Diverse Clinical Presentations of C3 Dominant Glomerulonephritis
doi 10.3389/fmed.2020.00293
- 4,877 views
- 4 citations
OPINION
Published on 22 May 2020
An Update in Drug-Induced Thrombotic Microangiopathy
doi 10.3389/fmed.2020.00212
- 15,885 views
- 25 citations
Published in
Frontiers in Medicine
- Hematology
Impact
- 51kTopic views
- 39kArticle views
- 10kArticle downloads